- Home
- ES vs GH Comparison
ES vs GH Comparison
Compare ES & GH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | ES | GH |
|---|---|---|
| Founded | 1927 | 2011 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Electric Utilities: Central | Medical Specialities |
| Sector | Utilities | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 28.1B | 22.9B |
| IPO Year | 1994 | 2018 |
Fundamental Metrics
Financial Performance| Metric | ES | GH |
|---|---|---|
| Price | $70.83 | $161.58 |
| Analyst Decision | Hold | Strong Buy |
| Analyst Count | 11 | 19 |
| Target Price | $71.00 | ★ $119.79 |
| AVG Volume (30 Days) | ★ 1.8M | 1.8M |
| Earning Date | 05-06-2026 | 05-07-2026 |
| Dividend Yield | ★ 4.58% | N/A |
| EPS Growth | ★ 100.88 | 6.74 |
| EPS | ★ 1.75 | N/A |
| Revenue | ★ $13,547,244,000.00 | $982,021,000.00 |
| Revenue This Year | N/A | $33.30 |
| Revenue Next Year | $3.77 | $28.27 |
| P/E Ratio | $40.47 | ★ N/A |
| Revenue Growth | 13.83 | ★ 32.88 |
| 52 Week Low | $62.45 | $53.40 |
| 52 Week High | $76.57 | $176.58 |
Technical Indicators
Market Signals| Indicator | ES | GH |
|---|---|---|
| Relative Strength Index (RSI) | 44.57 | 55.36 |
| Support Level | $70.62 | $153.82 |
| Resistance Level | $71.30 | $174.19 |
| Average True Range (ATR) | 1.06 | 6.71 |
| MACD | -0.07 | -0.05 |
| Stochastic Oscillator | 34.38 | 62.85 |
Price Performance
Historical ComparisonAbout ES Eversource Energy (D/B/A)
Eversource Energy is a diversified holding company with subsidiaries that provide rate-regulated electric, gas, and water distribution service to more than 4 million customers in the Northeast US. Eversource expanded its service territories with acquisitions of NStar (2012), Aquarion (2017), and Columbia Gas (2020). In 2024 Eversource exited its 50% partnership with European utility Orsted to develop 2 gigawatts of offshore wind projects in the Northeast US. It plans to sell Aquarion in 2026. The company exited most of its unregulated businesses in 2006.
About GH Guardant Health Inc.
Guardant Health, based in Redwood City, California, is a leader in liquid-based cancer tests for clinical and research use. The company's main franchises are Guardant360 for genomic profiling of tumors, Reveal for molecular residual disease testing, and Shield for colorectal cancer screening. Additionally, Guardant offers research development services such as regulatory approval consultancy and clinical trial referrals.